THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA

被引：0
|
作者：
Barratt, Jonathan [1 ]
Tumlin, James A. [2 ]
Suzuki, Yusuke [3 ]
Kao, Amy [4 ]
Aydemir, Aida [5 ]
Zima, Yulia [5 ]
Appel, Gerald [6 ]
机构：
[1] Leicester Gen Hosp, John Walls Renal Unit, Leicester, Leics, England
[2] Emory Univ, Sch Med, GA Nephrol, Atlanta, GA USA
[3] Juntendo Univ, Fac Med, Dept Nephrol, Tokyo, Japan
[4] EMD Serono Res & Dev Inst Inc, Immunol, Billerica, MA USA
[5] EMD Serono Res & Dev Inst Inc, Billerica, MA USA
[6] Columbia Univ, Med Ctr, Div Nephrol & Hypertens, New York, NY USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO039
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [1] A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of Telitacicept in Patients with IgA Nephropathy and Persistent Proteinuria
    Lv, Jicheng
    Liu, Lijun
    Hao, Chuan-Ming
    Li, Guisen
    Fu, Ping
    Xing, Guangqun
    Zheng, Hongguang
    Chen, Nan
    Caili, Wang
    Luo, Ping
    Qiong, Xie D.
    Zuo, Li
    Wang, Yue
    Li, Rongshan
    Mao, Yonghui
    Dong Shaoshao
    Zhang, Pengfei
    Zheng, Hui X.
    Wang, Wenxiang
    Li, Lin
    Jiao, Wenjuan
    Fang, Jianmin
    Zhang, Hong
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B10 - B10
  • [2] Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria
    Barratt, Jonathan
    Tumlin, James
    Suzuki, Yusuke
    Kao, Amy
    Aydemir, Aida
    Pudota, Kishore
    Jin, Hulin
    Guehring, Hans
    Appel, Gerald
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (08): : 1831 - 1841
  • [3] Efficacy and Safety of Atacicept in Patients with Systemic Lupus Erythematosus: Results of a 24-Week Randomized, Placebo-Controlled, Phase IIb Study
    Merrill, Joan T.
    Wallace, Daniel J.
    Wax, Stephen
    Kao, Amy
    Fraser, Patricia
    Chin, Wai
    Isenberg, David A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
    Lafayette, Richard
    Barbour, Sean
    Israni, Rubeen
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lin, Celia J. F.
    Barratt, Jonathan
    [J]. KIDNEY INTERNATIONAL, 2024, 105 (06) : 1306 - 1315
  • [5] Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia
    Bashir, Mustafa
    Paredes, Angelo
    Frias, Juan
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristen
    Gottwald, Mildred
    Chang, William
    Yan, Andrew
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S617 - S617
  • [6] Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Bolliger, Chris T.
    Issa, Jaqueline S.
    Posadas-Valay, Rodolfo
    Safwat, Tarek
    Abreu, Paula
    Correia, Eurico A.
    Park, Peter W.
    Chopra, Pravin
    [J]. CLINICAL THERAPEUTICS, 2011, 33 (04) : 465 - 477
  • [7] EFFICACY AND SAFETY OF ATACICEPT IN PATIENTS WITH HIGH DISEASE ACTIVITY IN A 24-WEEK, RANDOMIZED, PLACEBO-CONTROLLED, PHASE IIB STUDY (ADDRESS II)
    Merrill, J. T.
    Wallace, D. J.
    Kao, A.
    Mateo, C. Vazquez
    Fraser, P. A.
    Chang, P.
    Isenberg, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 856 - 856
  • [8] A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis
    Khanna, Dinesh
    Denton, Christopher P.
    Furst, Daniel E.
    Mayes, Maureen D.
    Matucci-Cerinic, Marco
    Smith, Vanessa
    de Vries, Dick
    Ford, Paul
    Bauer, Yasmina
    Randall, Matthew J.
    Ebrahimpoor, Mitra
    Kupcsik, Laszlo
    Stiers, Pieter-Jan
    Deberdt, Liesbeth
    Prasad, Niyati
    Lim, Sharlene
    Pujuguet, Philippe
    Ahmed, Sohail
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 (08) : 1434 - 1444
  • [9] A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder
    Montgomery, SA
    Nil, R
    Dürr-Pal, N
    Loft, H
    Boulenger, JP
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1270 - 1278
  • [10] LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282)
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia D.
    Bashir, Mustafa
    Frias, Juan Pablo
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristin
    Gottwald, Mildred
    Chang, William
    Yan, Andrew Z.
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen A.
    [J]. HEPATOLOGY, 2020, 72 : 1022 - 1023
12345